Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the ...

Researchers have identified six new biomarkers that could detect kidney injury faster and with more sensitivity, advancing safer drug development and improving health outcomes for patients.

Genialis and Debiopharm expand collaboration to develop RNA-based predictive biomarkers for DDR therapies, advancing precision oncology.

The literature throws up dozens of new potential biomarkers each month but too many of these studies lack sufficient rigor for translation into drug development, let alone regulatory qualification.

Discover how precision medicine and FDA's Project Optimus are transforming clinical trials in oncology drug development.

This enables precise quantification across protein abundances and supports novel biomarker discovery in drug and diagnostic development. Experts from the Women’s Brain Foundation and bit.bio will ...

Now, researchers have identified six new biomarkers that could detect kidney injury faster and with more sensitivity, advancing safer drug development and improving health outcomes for patients.

Neuraly and Enigma Biomedical have signed an agreement for PMI04, a positron emission tomography (PET) imaging biomarker for ...

DDR is a promising arena for the development of precision ... enables rapid configuration of biomarkers across the entire landscape of cancer drug targets, including DDR. Trained on hundreds ...